Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller
Spruce Biosciences appointed Eric Jordan as VP of Marketing and Tina Gullotta as VP of Finance and Corporate Controller to strengthen its commercial and financial infrastructure. The hires are timed to prepare for the potential U.S. FDA approval and commercial launch of TA-ERT, the company’s lead therapy for Sanfilippo Syndrome Type B.
Key figures
- Total rsus granted
- 7000
- Rsu grant per executive
- 3500
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.